What 22 Analyst Ratings Have To Say About Edwards Lifesciences
What 22 Analyst Ratings Have To Say About Edwards Lifesciences
关于爱德华生命科学的22个分析师评级，以下是他们的观点。
An in-depth...Across the recent three months, 22 analysts have shared their insights on Edwards Lifesciences (NYSE:EW), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月中，22位分析师分享了他们对纽交所（NYSE:EW）的见解，表达了从看好到看淡的各种观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $87.23, along with a high estimate of $110.00 and a low estimate of $70.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 11.29%.
提供更深入的见解，分析师已经建立了12个月的价格目标，显示出平均目标为87.23美元，高估值为110.00美元，低估值为70.00美元。情绪负面转变显而易见，由于分析师已将平均价目标下调了11.29%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
An in-depth...
对纽交...
登录免费看全文
登录/注册